Patent opposition case against Gilead’s long-acting HIV injectable drug, comes up this week – BusinessLine

Patent opposition case against Gilead’s long-acting HIV injectable drug, comes up this week  BusinessLineHIV drugs: Indian Patent Office to hear plea against US firm  The Indian ExpressActivists to oppose pharma major’s patent claims on new HIV drug  Deccan HeraldPatent applications for HIV prevention drug opposed in India  The HinduUS-based pharma giant Gilead Sciences wants HIV drug Lenacapavir patented  Business Standard Patent opposition case against Gilead’s long-acting HIV injectable drug, comes up this week  BusinessLineHIV drugs: Indian Patent Office to hear plea against US firm  The Indian ExpressActivists to oppose pharma major’s patent claims on new HIV drug  Deccan HeraldPatent applications for HIV prevention drug opposed in India  The HinduUS-based pharma giant Gilead Sciences wants HIV drug Lenacapavir patented  Business Standard  Top stories – Google News